Preliminary Study of the Added Value of T1 Mapping in Multiparametric MRI Radiomics for Noninvasive Prediction of Biomarkers and Pathological Features in Breast Cancer
Academic Radiology · 2026-09
DOI: 10.1016/j.acra.2026.08.083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic Radiology, 2026-09. Verfasst von Chun Lian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Peking University Shenzhen Hospital, Shenzhen, China (C.L., Y.H., J.L., D.A., J.L., G.L., R.H., Y.D. ). Die Arbeit nennt 38 Literaturangaben. Gefördert von: Shenzhen Science and Technology Innovation Committee, Peking University Shenzhen Hospital, Shenzhen Science and Technology Innovation Program.
Abstract (Originalsprache)
RATIONALE AND OBJECTIVES: This study presents a preliminary effort to quantify the value of T1 mapping by comparing radiomics models from conventional multiparametric magnetic resonance imaging (mpMRI) with and without T1 mapping to improve noninvasive breast cancer biological assessment. MATERIALS AND METHODS: All enrolled patients underwent mpMRI examinations, including T1 mapping, T2-weighted imaging, diffusion-weighted imaging, and dynamic contrast-enhanced (DCE) sequences. Images were registered to DCE-MRI using Elastix. Radiomics features were extracted via PyRadiomics and normalized. Five models were built and compared: conventional mpMRI, non‑contrast mpMRI with T1 mapping, comprehensive mpMRI, clinical, and integrated clinicoradiologic models. Feature selection was conducted using analysis of variance and least absolute shrinkage and selection operator regression. Model performance was evaluated using the area under the curve (AUC), with 95% confidence intervals estimated via 1000 bootstrap resamples of the test set. Model interpretability was assessed using SHapley Additive exPlanations (SHAP) analysis and nomograms. RESULTS: A total of 101 breast cancer patients were included (estrogen receptor [ER]+/-: 85/16; progesterone receptor [PR]+/-: 75/26; human epidermal growth factor receptor 2 [HER2]+/-: 56/45; Ki-67 high/low: 57/34; histological grade high/low: 28/68; axillary lymph node [ALN]+/-: 39/62). The integrated clinicoradiologic model achieved the highest predictive performance, with test AUCs of 0.944 for ER, 0.990 for PR, 0.956 for HER2, 0.862 for Ki-67, 0.931 for histological grade, and 0.912 for ALN status, outperforming all ablated models. SHAP analysis identified key radiomics features for grade and nodal status, while nomograms offered intuitive individualized risk assessment. CONCLUSION: Radiomics models incorporating T1 mapping with conventional mpMRI, particularly when combined with clinical data, provide a noninvasive approach for characterizing breast cancer biology and may aid personalized clinical management. Nevertheless, these findings remain preliminary and require validation in larger, multicenter cohorts before clinical translation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Imaging, Peking University Shenzhen Hospital, Shenzhen, China (C.L., Y.H., J.L., D.A., J.L., G.L., R.H., Y.D. ).
- Department of Radiology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China (K.Z.); Guangdong Provincial Key Laboratory of Bone and Joint Degenerative Diseases, The Third Affiliated Hospital…
- Department of Medical Imaging, Peking University Shenzhen Hospital, Shenzhen, China (C.L., Y.H., J.L., D.A., J.L., G.L., R.H., Y.D. ); PKU-Shenzhen Clinical Institute of Shantou University Medical College, Shenzhen, Chi…
- Department of Medical Imaging, Peking University Shenzhen Hospital, Shenzhen, China (C.L., Y.H., J.L., D.A., J.L., G.L., R.H., Y.D. ); Shenzhen University Medical School, Shenzhen, China (J.L., Y.D.).
- Department of Radiology, Shenzhen People's Hospital, Shenzhen, China (L.Z.).
- Department of Research & Development, Yizhun Medical AI Co. Ltd, Beijing, China (J.C., H.L.); Institut du Cerveau, Hôpital Pitié-Salpêtrière, Paris, France (J.C.).
Förderung
- Shenzhen Science and Technology Innovation Committee
- Peking University Shenzhen Hospital
- Shenzhen Science and Technology Innovation Program
- Guangdong Provincial Medical Research Foundation
Zitieren
APA
Lian, C., He, Y., Liang, J., Zhao, K., Aishanjiang, D., Lin, J., Li, G., Zhuang, L., Chen, J., Liu, H., Huang, R., & Dai, Y. (2026). Preliminary Study of the Added Value of T1 Mapping in Multiparametric MRI Radiomics for Noninvasive Prediction of Biomarkers and Pathological Features in Breast Cancer. Academic Radiology. https://doi.org/10.1016/j.acra.2026.08.083
Vancouver
Lian C, He Y, Liang J, Zhao K, Aishanjiang D, Lin J, et al. Preliminary Study of the Added Value of T1 Mapping in Multiparametric MRI Radiomics for Noninvasive Prediction of Biomarkers and Pathological Features in Breast Cancer. Academic Radiology. 2026. doi:10.1016/j.acra.2026.08.083
BibTeX
@article{Lian2026,
author = {Lian, Chun and He, Yan and Liang, Jianle and Zhao, Kaixuan and Aishanjiang, Dilinuer and Lin, Jiajia and Li, Guozheng and Zhuang, Lulu and Chen, Jiaqi and Liu, Hao and Huang, Rong and Dai, Yi},
title = {Preliminary Study of the Added Value of T1 Mapping in Multiparametric MRI Radiomics for Noninvasive Prediction of Biomarkers and Pathological Features in Breast Cancer},
journal = {Academic Radiology},
year = {2026},
doi = {10.1016/j.acra.2026.08.083}
}
EUVIMED